Lernapharm (Loris) Inc.

Form 483 issued May 6, 2022 · St. Laurent, Canada

Inspection
Apr 28 – May 6, 2022
Investigator
Alan P. Kurtzberg
Observations
2
Pages
2
FEI number
3004158845

In short: On May 6, 2022, FDA issued a Form 483 with 2 observations to Lernapharm (Loris) Inc. in St. Laurent, Quebec (FEI 3004158845) after an inspection that ran Apr 28 – May 6, 2022. The investigator was Alan P. Kurtzberg. Most observations concern packaging & labeling and laboratory controls; the most-cited regulation is 21 CFR 211.125 (labeling issuance).

At a glance

Packaging & labeling and laboratory controls account for 2 of 2 observations.

Packaging & labeling1
Laboratory controls1

Most cited: 21 CFR 211.125(c) (1×) · 211.165(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Discrepancies found outside preset limits when reconciling the quantities of labeling issued, used and…

  2. 02

    Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Lernapharm (Loris) Inc.?

FDA listed 2 observations on this Form 483, mostly about packaging & labeling and laboratory controls. The most-cited regulation is 21 CFR 211.125 (labeling issuance). The opening words of each observation are shown on this page.

Who inspected Lernapharm (Loris) Inc.?

Alan P. Kurtzberg is named on this Form 483, for the inspection of Apr 28 – May 6, 2022. Each investigator has a profile showing what they cite most.

When was Lernapharm (Loris) Inc. inspected by FDA?

The inspection ran Apr 28 – May 6, 2022, and the Form 483 is dated May 6, 2022.

How do I get the full Form 483 for Lernapharm (Loris) Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free